These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 17824494)

  • 1. Cost-effectiveness of a chemoprophylactic intervention with single dose rifampicin in contacts of new leprosy patients.
    Idema WJ; Majer IM; Pahan D; Oskam L; Polinder S; Richardus JH
    PLoS Negl Trop Dis; 2010 Nov; 4(11):e874. PubMed ID: 21072235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The State of Affairs in Post-Exposure Leprosy Prevention: A Descriptive Meta-Analysis on Immuno- and Chemo-Prophylaxis.
    Schoenmakers A; Mieras L; Budiawan T; van Brakel WH
    Res Rep Trop Med; 2020; 11():97-117. PubMed ID: 33117053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CHEMOPROPHYLAXIS TO CONTROL LEPROSY AND THE PERSPECTIVE OF ITS IMPLEMENTATION IN BRAZIL: A PRIMER FOR NON-EPIDEMIOLOGISTS.
    Cunha SS; Bierrenbach AL; Barreto VH
    Rev Inst Med Trop Sao Paulo; 2015 Dec; 57(6):481-7. PubMed ID: 27049701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoprophylaxis in the prevention of leprosy.
    Smith WC
    BMJ; 2008 Apr; 336(7647):730-1. PubMed ID: 18390497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of leprosy using rifampicin as chemoprophylaxis.
    Bakker MI; Hatta M; Kwenang A; Van Benthem BH; Van Beers SM; Klatser PR; Oskam L
    Am J Trop Med Hyg; 2005 Apr; 72(4):443-8. PubMed ID: 15827283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemoprophylaxis is effective in the prevention of leprosy in endemic countries: a systematic review and meta-analysis. MILEP2 Study Group. Mucosal Immunology of Leprosy.
    Smith CM; Smith WC
    J Infect; 2000 Sep; 41(2):137-42. PubMed ID: 11023757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effect of the combination BCG vaccination and rifampicin prophylaxis in leprosy prevention.
    Schuring RP; Richardus JH; Pahan D; Oskam L
    Vaccine; 2009 Nov; 27(50):7125-8. PubMed ID: 19786134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protecting people against leprosy: chemoprophylaxis and immunoprophylaxis.
    Richardus JH; Oskam L
    Clin Dermatol; 2015; 33(1):19-25. PubMed ID: 25432807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Report of the workshop on the use of chemoprophylaxis in the control of leprosy held in Amsterdam, The Netherlands on 14 December 2006.
    Oskam L; Mi B
    Lepr Rev; 2007 Jun; 78(2):173-85. PubMed ID: 17824494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of rifampicin chemoprophylaxis in preventing leprosy in patient contacts: a systematic review of quantitative and qualitative evidence.
    Ferreira SMB; Yonekura T; Ignotti E; Oliveira LB; Takahashi J; Soares CB
    JBI Database System Rev Implement Rep; 2017 Oct; 15(10):2555-2584. PubMed ID: 29035966
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.